# EDGAR Filing Document

**Accession Number:** 0001383088
**File Stem:** 0001477932-23-001019
**Filing Date:** 2023-2
**Character Count:** 92642
**Document Hash:** 4f29997a69001efc4a027d1e2725a11e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-23-001019.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001477932-23-001019

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 51

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CYTTA CORP.
- **CENTRAL INDEX KEY:** 0001383088
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **IRS NUMBER:** 980505761
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-139699
- **FILM NUMBER:** 23630896

**BUSINESS ADDRESS:**
- **STREET 1:** 5450 W SAHARA AVE.
- **STREET 2:** SUITE 300A
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89146
- **BUSINESS PHONE:** 855-511-4426

**MAIL ADDRESS:**
- **STREET 1:** 5450 W SAHARA AVE.
- **STREET 2:** SUITE 300A
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89146

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Cytta Corp.
- **DATE OF NAME CHANGE:** 20061208

?xml version="1.0" encoding="utf-8"?cyca_10q.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

☒&nbsp;&nbsp;&nbsp;&nbsp; **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarter ended: **December 31, 2022**

OR

☐&nbsp;&nbsp;&nbsp;&nbsp; **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the Transition Period from ___________ to____________

Commission File Number: **333-257458**

---

| |
|:---|
| **CYTTA CORP.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Nevada** | **98-0505761** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |

---

**5450 W Sahara Ave Suite 300A**

**<u>Las Vegas NV 89146</u>**

(Address of principal executive offices) (zip code)

**<u>(702) 900-7022</u>**

(Registrant's telephone number, including area code)

**<u>Not applicable</u>.**

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading** <br>**Symbol(s)** | **Name of each exchange** <br>**on which registered** |
| None | N/A | N/A |

---

Securities registered pursuant to Section 12(g) of the Act: **Common Stock, $0.001 par value**

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated Filer | ☐ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of February 10, 2023, there were 383,685,670 shares outstanding of the registrant's common stock, $0.001 par value per share.

**CYTTA CORP.**

**INDEX**

---

| | | | |
|:---|:---|:---|:---|
| **PART I. FINANCIAL INFORMATION** | **PART I. FINANCIAL INFORMATION** | **PART I. FINANCIAL INFORMATION** |  |
|  | ITEM 1 | Financial Statements (Unaudited) |  |
|  |  | [Condensed Balance Sheets as of December 31, 2022, and September 30, 2022 (Unaudited)](#bs) | 3 |
|  |  | [Condensed Statement of Operations for the three months ended December 31, 2022, and 2021 (Unaudited)](#so) | 4 |
|  |  | [Condensed Statement of Changes in Stockholders' Deficit for the three months ended December 31, 2022, and 2021 (Unaudited)](#sse) | 5 |
|  |  | [Condensed Statement of Cash Flows for the three months ended December 31, 2022, and 2021 (Unaudited)](#cs) | 6 |
|  |  | [Notes to Interim Unaudited Condensed Financial Statements](#note) | 7 |
|  | [ITEM 2.](#it2) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#it2) | 15 |
|  | [ITEM 3.](#pit3) | [Quantitative and Qualitative Disclosures About Market Risk](#pit3) | 19 |
|  | [ITEM 4.](#it4) | [Controls and Procedures](#it4) | 19 |
| **[PART II. OTHER INFORMATION](#p2)** | **[PART II. OTHER INFORMATION](#p2)** | **[PART II. OTHER INFORMATION](#p2)** |  |
|  | [ITEM 1.](#pit1) | [Legal Proceedings](#pit1) | 21 |
|  | [ITEM 1A.](#pit1a) | [Risk Factors](#pit1a) | 21 |
|  | [ITEM 2.](#pit2) | [Unregistered Sales of Equity Securities and Use of Proceeds](#pit2) | 21 |
|  | [ITEM 3.](#pit3) | [Defaults Upon Senior Securities](#pit3) | 21 |
|  | [ITEM 4.](#pit4) | [Mine Safety Disclosures](#pit4) | 21 |
|  | [ITEM 5.](#pit5) | [Other Information](#pit5) | 21 |
|  | [ITEM 6.](#pit6) | [Exhibits](#pit6) | 22 |

---

---

| |
|:---|
| 2 |
| *[**Table of Contents**](#Toc1)* |

---

---

| | | |
|:---|:---|:---|
| **CYTTA CORP** | **CYTTA CORP** | **CYTTA CORP** |
| **BALANCE SHEETS** | **BALANCE SHEETS** | **BALANCE SHEETS** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
|  | **December 31,** | **September 30,** |
|  | **2022** | **2022** |
| **ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash | $143341 | $755122 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 4995 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 26927 | 32897 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Current Assets | 175263 | 788019 |
| Property and equipment, net | 111086 | 122990 |
| **TOTAL ASSETS** | $286349 | $911009 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $282009 | $180633 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Related party liabilities | 121041 | 180407 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividend payable | 33427 | 33427 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 26763 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock to be issued | 54750 | 54750 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Current Liabilities** | 517990 | 449217 |
| **COMMITMENTS AND CONTINGENCIES** | - | - |
| **Stockholders' Equity (Deficit)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock PAR VALUE $0.001; (100,000,000 shares authorized) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series C Preferred Stock par value $0.001; (12,000,000 shares authorized |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and 600,000 issued and outstanding) | 600 | 600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series D Preferred Stock par value $0.001; (10,000,000 shares authorized  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and 50,000 shares issued and outstanding) | 50 | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series E Preferred Stock par value $0.001; (13,650,000 shares authorized |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and -0- (December 31, 2022) and 13,650,000 (September 30, 2022) issued and outstanding) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series F Preferred Stock par value $0.001; (10,000,000 shares authorized |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and -0- issued and outstanding) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock par value $.001; (500,000,000 shares authorized  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and 383,685,670 (December 31) and 379,760,670 (September 30) shares issued and outstanding) | 383686 | 379761 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid in capital | 28359738 | 27956388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated Deficit | (28975715) | (27875007) |
| Total Stockholders' Equity (Deficit) | (231641) | 461792 |
| **TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)** | $286349 | $911009 |

---

The accompanying notes are an integral part of these statements

---

| |
|:---|
| 3 |
| *[**Table of Contents**](#Toc1)* |

---

---

| | | |
|:---|:---|:---|
| **CYTTA CORP** | **CYTTA CORP** | **CYTTA CORP** |
| **STATEMENT OF OPERATIONS** | **STATEMENT OF OPERATIONS** | **STATEMENT OF OPERATIONS** |
| (Unaudited) | (Unaudited) | (Unaudited) |
|  | **For the Three Months**<br>**Ended December 31,** | **For the Three Months**<br>**Ended December 31,** |
|  | **2022** | **2021** |
| Revenues | $5706 | $937 |
| Operating Expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administration- related party expenses | 177868 | 465282 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative- other | 928575 | 653704 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 1106443 | 1118986 |
| Loss from Operations | (1100737) | (1118049) |
| Other expenses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 26 | 46057 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | (55) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Other Expenses (Income) | (29) | 46057 |
| Loss before income taxes | (1100708) | (1164106) |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | - | - |
| Net loss | $(1100708) | $(1164106) |
| Loss per share, basic and diluted | $(0.00) | $(0.00) |
| Weighted average shares outstanding Basic and diluted | 380882100 | 300648716 |

---

The accompanying notes are an integral part of these statements

---

| |
|:---|
| 4 |
| *[**Table of Contents**](#Toc1)* |

---

---

| | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) | **Cytta Corp.**<br>Statement of Changes in Stockholders' Equity (Deficit)<br>The Three Months December 31, 2022<br>(Unaudited) |
|  | **Series C**<br>**Preferred Stock** | **Series C**<br>**Preferred Stock** | **Series D**<br>**Preferred Stock** | **Series D**<br>**Preferred Stock** | **Series E**<br>**Preferred Stock** | **Series E**<br>**Preferred Stock** | **Series F**<br>**Preferred Stock** | **Series F**<br>**Preferred Stock** | **Common**<br>**Stock** | **Common**<br>**Stock** | **Additional**<br>**Paid-in** | **Accumulated** | **Total**<br>**Stockholders'**<br>**Equity**  |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Capital** | **Deficit** | **(Deficit)** |
| Balance September 30, 2022 | 600000 | $600 | 50000 | $50 |  | $- |  | $- | 379760670 | $379761 | $27956388 | $(27875007) | $461792 |
| Common stock issued for services |  |  |  |  |  |  |  |  | 3925000 | 3925 | 403350 |  | 407275 |
| Net loss for the three months ended December 31, 2022 |  |  |  |  |  |  |  |  |  |  |  | (1100708) | (1100708) |
| Balances December 31, 2022 | 600000 | $600 | 50000 | $50 |  | $- |  | $- | 383685670 | $383686 | $28359738 | $(28975715) | $(231641) |

---

---

| | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** |
| Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity | Statement of Changes in Stockholders' Equity |
| The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 | The Three Months Ended December 31, 2021 |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
|  | **Series C**<br>**Preferred Stock** | **Series C**<br>**Preferred Stock** | **Series D**<br>**Preferred Stock** | **Series D**<br>**Preferred Stock** | **Series E**<br>**Preferred Stock** | **Series E**<br>**Preferred Stock** | **Series F**<br>**Preferred Stock** | **Series F**<br>**Preferred Stock** | **Common**<br>**Stock** | **Common**<br>**Stock** | **Additional**<br>**Paid-in** | **Accumulated** | **Total**<br>**Stockholders'** |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Capital** | **Deficit** | **Equity** |
| Balance September 30, 2021 | 600000 | $600 | 50000 | $50 | 13650000 | $13650 |  | $- | 296236627 | $296237 | $23330612 | $(22774905) | $866244 |
| Series F Preferred stock issued for cash |  |  |  |  |  |  | 59270000 | 59270 |  |  | 2904230 |  | 2963500 |
| Common stock issued for services |  |  |  |  |  |  |  |  | 6250000 | 6250 | 852850 |  | 859100 |
| Common stock issued for accounts payable |  |  |  |  |  |  |  |  | 909091 | 909 | 299091 |  | 300000 |
| Common stock issued for conversion of Series E Preferred Stock |  |  |  |  | (13650000) | (13650) |  |  | 13650000 | 13650 |  |  |  |
| Common stock issued for conversion of Series F Preferred Stock |  |  |  |  |  |  | (59270000) | (59270) | 59270000 | 59270 |  |  |  |
| Loss for the three months ended December 31, 2021 |  |  |  |  |  |  |  |  |  |  |  | (1164106) | (1164106) |
| Balance December 31, 2021 | 600000 | $600 | 50000 | $50 | 0 | $- | - | $- | 376315718 | $376316 | $27386783 | $(23939011) | $3824738 |

---

The accompanying notes are an integral part of these statements

---

| |
|:---|
| 5 |
| *[**Table of Contents**](#Toc1)* |

---

---

| | | |
|:---|:---|:---|
| **Cytta Corp.** | **Cytta Corp.** | **Cytta Corp.** |
| Statements of Cash Flows | Statements of Cash Flows | Statements of Cash Flows |
| (Unaudited) | (Unaudited) | (Unaudited) |
|  | **For the Three Months**<br>**Ended December 31,** | **For the Three Months**<br>**Ended December 31,** |
|  | **2022** | **2021** |
| CASH FLOWS FROM OPERATING ACTIVITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(1100708) | $(1164106) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expenses for services | 407275 | 455985 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 11904 | 11904 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in Operating Assets and Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory  |  | (52300) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Receivable | (4995) | 27694 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 5969 | 3440 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vendor deposits |  | 50400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 101376 | 4533 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable-related party | (59365) | 128682 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividend payable |  | 12394 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 26763 | (936) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (611781) | (522310) |
| CASH FLOWS FROM INVESTING ACTIVITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | - | - |
| CASH FLOWS FROM FINANCING ACTIVITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from stock subscriptions | - | 2963500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | - | 2963500 |
| NET CHANGE IN CASH | (611781) | 2441190 |
| CASH AT BEGINNING OF PERIOD | 755122 | 173196 |
| CASH AT END OF PERIOD | $143341 | $2614386 |
| SUPPLEMENTAL CASH FLOW DISCLOSURES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $- | $- |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for income taxes | $- | $- |
| NON-CASH INVESTING AND FINANCING ACTIVITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued for services | $407275 | $560267 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued for accounts payable | $- | $300000 |

---

The accompanying notes are an integral part of these statements

---

| |
|:---|
| 6 |
| *[**Table of Contents**](#Toc1)* |

---

**Cytta Corp.**

Notes to Financial Statements

December 31, 2022

**NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS**

Cytta Corp., ("Cytta" or the "Company") was incorporated on May 30, 2006 under the laws of the State of Nevada. It is located in Las Vegas, Nevada. Cytta is in the business of imagineering, developing and securing disruptive technologies.

**NOTE 2 - GOING CONCERN**

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2022, the Company had an accumulated deficit of $28,975,715 and has also generated losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern.

In December 2019, a novel strain of coronavirus (COVID-19) emerged. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company's business and the duration for which it may have an impact cannot be determined at this time.

The Company develops and distributes proprietary technology that radically shifts how video is streamed, consumed, transferred and stored. Our proprietary SUPR Stream is the technology at the core of our products, designed specifically for streaming and storing HD, 4K, and higher resolution video. The IGAN (Incident Global Area Network) Incident Command System (ICS) seamlessly streams and stores all relevant video and audio during emergency situations. This creates real-time situational awareness for police, firefighters, first responders, EMS, and their command centers. Our products work in size, weight, and power-constrained (SWaP) operating environments, and evolved through use in the military by meeting the need to stream multiple HD, 4K, and 4K+ video feeds with ultra-low latency, bandwidth, and power consumption. The Company is taking this streaming, storage, and transfer technology to enterprises that would like to send more high-quality videos with fewer resources. All of our products are manufactured in the USA.

The Company intends to fund operations through equity financing arrangements, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the foreseeable future.

**NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

*Basis of Presentation*

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission ("SEC"). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company's management, the accompanying unaudited condensed financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of December 31, 2022, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended December 31, 2022, are not necessarily indicative of the operating results for the full fiscal year or any future period.

---

| |
|:---|
| 7 |
| *[**Table of Contents**](#Toc1)* |

---

*Use of Estimates*

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

*Cash and Cash Equivalents*

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at December 31, 2022, and 2021.

*Accounts Receivable*

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

*Prepaid expenses*

The Company considers expenses or services paid for prior to the period the expense is completed to be recorded as a prepaid expense. Included in this account is the value of common stock issued to consultants. Such issuances are pursuant to consulting agreements that can have a one-to-two-year term. The Company amortized the value of the stock issued over the term of the agreement. The activity for the three months ended December 31, 2022 and 2021 is summarized as:

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2022** | **2021** |
| Balance beginning of period | $32897 | $772394 |
| Value of common stock issued |  | 860267 |
| Amortization of stock-based compensation |  | (425985) |
| Other prepaid expense activity | (5970) | (3440) |
|  | $26927 | $1203236 |

---

*Inventory*

Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs include finished goods and component parts. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues. Inventory as of December 31, 2022, and 2021, was $-0- and $-0-, respectively.

*Property and equipment*

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

---

| | |
|:---|:---|
| Vehicles and equipment | 5 years |
| Software | 3 years |

---

---

| |
|:---|
| 8 |
| *[**Table of Contents**](#Toc1)* |

---

*Fair value of financial instruments*

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

*Revenue recognition*

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. The Company has no outstanding contracts with any of its' customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms.

*Stock-based compensation*

The Company accounts for its stock based compensation under the recognition and measurement principles of the fair value recognition provisions of Statement of Financial Accounting Standards No. 123 (revised 2004) "Share-Based Payment" ("SFAS No. 123R")(ASC 718) using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and the Financial Accounting Standards Board Emerging Issues Task Force Issue No. 96-18 "Accounting For Equity Instruments That Are Issued To Other Than Employees For Acquiring, Or In Conjunction With Selling Goods Or Services" ("EITF No. 96-18") for share-based payment transactions with parties other than employees provided in SFAS No. 123(R) (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the third-party performance is complete or the date on which it is probable that performance will occur.

---

| |
|:---|
| 9 |
| *[**Table of Contents**](#Toc1)* |

---

*Income taxes*

The Company accounts for income taxes under Statement of Financial Accounting Standards No. 109 "Accounting for Income Taxes" ("SFAS No. 109") (ASC 740). Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

*Cash flows reporting*

The Company follows the provisions of ASC 230 for cash flows reporting and accordingly classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.

*Reporting segments*

ASC 280 establishes standards for the way that public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographic areas and major customers. ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company's financial statements as substantially all of the Company's operations are conducted in one industry segment.

*Concentrations of Credit Risk*

The Company's financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company's management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.

*Earnings (Loss) Per Share of Common Stock*

The Company has adopted ASC 260-10-20, "Earnings per Share," ("EPS") which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.

*Recent Accounting Pronouncements*

Other than the above there have no recent accounting pronouncements or changes in accounting pronouncements during the three months ended December 31, 2022, that are of significance or potential significance to the Company.

---

| |
|:---|
| 10 |
| *[**Table of Contents**](#Toc1)* |

---

**NOTE 4 - PROPERTY AND EQUIPMENT**

The following table represents the Company's property and equipment as of December 31, 2022, and September 30, 2022:

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br>**2022** | **September 30,**<br>**2022** |
| Property and equipment | $230900 | $230900 |
| Accumulated depreciation | (119814) | (107910) |
| Property and equipment, net | $111086 | $122990 |

---

Depreciation expense was $11,904 for the three months ended December 31, 2022 and 2021, respectively.

**NOTE 5 - RELATED PARTY TRANSACTIONS**

**Related Party agreements and fees**

For the three months ended December 31, 2022, and 2021, the Company recorded expenses to related parties in the following amounts:

---

| | | |
|:---|:---|:---|
|  | **Three months ended**<br>**December 31,** | **Three months ended**<br>**December 31,** |
|  | **2022** | **2021** |
| Management fees, Chief Executive Officer (CEO) | $60000 | $145000 |
| Chief Technology Officer (CTO)  | 60000 | 145000 |
| Chief Administration Officer (CAO)  | 45000 | 159063 |
| Office rent and expenses | 12868 | 16219 |
| Total | $177868 | $465282 |

---

Effective June 1, 2021, the Company increased the monthly fee paid to its' CEO and CTO, from $12,000 to $15,000, respectively. On January 1, 2022, the Company increased the monthly fee to $18,000 for the CEO and CTO, respectively, and on February 1, 2022, the monthly fee for the CEO and CTO was increased to $20,000. For the three months ended December 31, 2021, the Company also recorded bonus expenses of $100,000, $100,000, and $90,000 for the CEO, CTO and CAO, respectively. Included in the CAO's compensation for the three months ended December 31, 2021, is the amortization of stock-based compensation expense of $39,063.

On October 25, 2020, the Company entered into a sublease with its CTO, whereby the Company agreed to an annual lease payment of $50,000. On October 26, 2021, renewed he lease for an additional year for $3,500 per month, and on October 26, 2022, the lease was renewed on a month to month basis. Included in office rent for the three months ended December 31, 2022, and 2021 is $10,500 and $14,663, respectively.

***Accounts payable, related parties***

As of December 31, 2022, and September 30, 2022, the Company owes $121,041 and $180,407 respectively to related parties as follows:

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br>**2022** | **September 30,**<br>**2022** |
| Management fees, Chief Executive Officer (CEO) | $10000 | $30000 |
| Bonus, CEO | 100000 | 100000 |
| Bonus and accounts payable, CTO | 11041 | 50407 |
| Total | $121041 | $180407 |

---

---

| |
|:---|
| 11 |
| *[**Table of Contents**](#Toc1)* |

---

**NOTE 6 - CAPITAL STOCK** 

*Common Stock*

The Company has authorized 500,000,000 common shares, par value $0.001. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. As of December 31, 2022, and September 30, 2022, there were 383,685,670 and 379,760,670, respectively, common shares issued and outstanding.

During the three months ended December 31, 2022, the following shares of common stock were issued:

· 3,925,000 shares of common issued for services. The Company valued the shares at $407,275 based on the price of the common stock on the date the Company agreed to issue the shares.

*Preferred Stock*

The Company has 100,000,000 shares authorized as preferred stock, par value $0.001 (the "Preferred Stock"), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.

*Series C Preferred Stock*

Under the terms of the Certificate of Designation of Series C Preferred Stock, 12,000,000 shares of the Company's preferred shares are designated as Series C Preferred Stock. Each share of Series C Preferred Stock is convertible into one hundred shares Common Stock and each share of Series C Preferred Stock is entitled to one hundred votes. As of December 31, 2022, and September 30, 2022, there were 600,000 shares of Series C Preferred Stock issued and outstanding.

*Series D Preferred Stock*

On September 30, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company's Series D Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series D Preferred Stock, 50,000 shares of the Company's preferred shares are designated as Series D Preferred Stock. Each share of Series D Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series D Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to two times the sum of all the number of shares of other classes of Corporation capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Corporation. On September 30, 2020, the Company issued 50,000 shares of Series D Preferred Stock to a Company controlled by the Company's CEO, in satisfaction of $1,347,894 of capital stock to be issued. As of December 31, 2022, and September 30, 2022, there were 50,000 shares of Series D Preferred Stock issued and outstanding.

*Series E Preferred Stock*

On June 2, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 13,650,000 (as amended on June 10, 2021) were designated as Series E Preferred Stock. Each share of Series E Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series E Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. As of September 30, 2021, there were 13,650,000 shares of Series E Preferred Stock issued and outstanding. During the year ended September 30, 2022, the holders converted the 13,650,000 shares of Series E Preferred Stock to 13,650,000 shares of common stock. As of December 31, 2002, and September 30, 2022, there were no shares of Series E Preferred stock issued and outstanding.

*Series F Preferred Stock*

On November 24, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 59,270,000 were designated as Series F Preferred Stock. Each share of Series F Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock at any time by the holder. For so long as any shares of the Series F Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. The Series F Preferred Stock automatically converts to common stock after the shares of common stock closing market price is at least $0.20 for twenty (20) consecutive trading days. During the year ended September 30, 2022, the Company sold 59,270,000 shares of Series F Preferred Stock at $0.05 per share and received proceeds of $2,963,750, and during the year ended September 30, 2022, the holders converted the 59,270,000 shares of Series F Preferred Stock to 59,270,000 shares of common stock. As of December 31, 2022, and September 30, 2022, there were no shares of Series F Preferred Stock issued and outstanding.

*Stock Payable (Capital stock to be issued)*

As of September 30, 2021, the Company had $323,583 of capital stock to be issued. During the year ended September 30, 2022, 4,000,000 shares of common stock was issued, which reduced the capital stock to be issued by $268,833. As of December 31, 2022, and September 30, 2022, the Company has $54,750 and $54,750, respectively, of capital stock to be issued, which is included in the liability section of the balance sheets presented herein.

---

| |
|:---|
| 12 |
| *[**Table of Contents**](#Toc1)* |

---

**NOTE 7 - COMMITMENTS AND CONTINGENCIES**

On November 24, 2020, a plaintiff (the "Plaintiff") filed a complaint in the State District Court for Clark County, Nevada, naming Cytta as a Defendant. The Plaintiff contends that the Company had breached an agreement. On or about January 15, 2021, the Defendant filed an Answer and Counterclaim in the litigation and contended that in fact the Plaintiff owed money to Cytta for having breached an earlier services agreement, of limited scope and duration, and was liable for defaming Cytta in various communications he had sent to certain persons or entities. Management has been contesting the matter vigorously. A bench trial was held in June 2022, and the court has not yet made a ruling.

On July 19, 2022, the Company entered an Investor Awareness Advisory Services Agreement with a third party. Pursuant to the agreement in exchange for $10,000 per month over the three-month term (the "Term") of the agreement, the third party will provide investor awareness advisory services (the "Services"). In addition, at the end of the Term, based upon the Company's satisfaction with the Services, the Company will issue 500,000 shares of common stock to the provider's designee. The shares were issued in December 2022.

On August 4, 2022 (the "Effective Date"), the Company entered a Consulting Agreement with a third party. Pursuant to the agreement in exchange for 1,300,000 shares of restricted common stock over the one-year term of the agreement, the third party will provide financial consulting services to the Company. The shares are to be issued on a pro-rata basis, whereby the initial shares were issued on August 8, 2022, with an additional issuance of 325,000 shares to be issued every 90 days thereafter. On December 2, 2022, the Company issued the second 325,000 shares and agreed to issue two additional tranches of 325,000 shares in ninety-day increments.

On November 16, 2022 (the "Effective Date"), the Company entered a Consulting Agreement with a third party. Pursuant to the agreement in exchange for 1,000,000 shares of restricted common stock over the one-year term of the agreement the third party will provide financial consulting services to the Company. On December 5, 2022, the Company issued 500,000 shares and agreed to issue 250,000 shares each at the beginning of months seven and eight of the agreement.

On December 2, 2022 (the "Effective Date"), the Company entered a Consulting Agreement with a third party. Pursuant to the agreement in exchange for 1,000,000 shares of restricted common stock.

On December 5, 2022, the Company issued 1,200,000 shares of common stock for services rendered pursuant to a consulting agreement. The Company also agreed to pay a monthly of $5,000 per month. Additionally for the three months ended December 31, 2022, the Company recorded stock compensation expense of $55,393, for the obligation to issue 500,000 shares of restricted common stock.

**NOTE 8 – LICENSE AGREEMENT**

On August 9, 2022, the Company signed an Intellectual Property License Agreement (the "IPLA") with Reticulate Micro, Inc. ("RM"). Pursuant to the ten-year term (the "Term") of IPPA, RM agreed to issue to the Company 5,100,000 shares of RM's Class A Common Stock and a royalty of 5% of net sales during the Term in exchange for the licensing of the Company's technology related to its' SUPR ISR (the Superior Utilization of Processing Resources- Intelligence, Surveillance and Reconnaissance).

RM, a Nevada corporation, was formed on June 22, 2022. Mr. Collins, the Company's' CTO is a founder, Director and President and Treasurer of RM. Mr. Chermak, the Company's COO is a founder, Director and Vice-president and Secretary of RM. Mr. Ansari isa founder and Director of RM. RM has also agreed to issue 1,600,000, 1,000,000 and 1,000,000 shares of Class B Common Stock to Mr. Collins. Mr. Chermak and Mr. Ansari, respectively. As of September 30, 2022, RM has 3,600,000 Class B Common Stock shares outstanding. Each share of the Class B Common Stock has voting rights whereby each share of Class B Common Stock equals 100 voting shares. Accordingly, as of December 31, 2022, and September 30, 2022, the Company's 5,100,000 shares of Class A Common Stock represent approximately 1.39% and 1.4%, respectively of the voting stock of RM. Each share of the Class B Common stock is also convertible into one share of Class A Common Stock.

The Company accounts for its interest in RM under the cost method of accounting. Due to RM just being formed at the time of the license agreement no value has been assigned to the investment.

---

| |
|:---|
| 13 |
| *[**Table of Contents**](#Toc1)* |

---

**NOTE 9 - INCOME TAXES**

The Company provides for income taxes under ASC 740, Accounting for Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely- than not that some or all of the deferred tax assets will not be realized.

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, there is a full valuation allowance provided against the Company's deferred tax assets as of December 31, 2022, and September 30, 2022.

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets meet the more-likely-than-not threshold for realizability. Accordingly, a full valuation allowance has been recorded against the Company's deferred tax assets as of December 31, 2022, and September 30, 2022.

As of December 31, 2022. And September 30, 2022, the Company has approximately $8,353,000 and $7,804,000, respectively, net operating loss carryforwards available to reduce future taxable income. As of December 31, 2022, and September 30, 2022, the Company has no material unrecognized tax benefits which would favorably affect the effective income tax rate in future periods, and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during the three months ended December 31, 2022, and 2021, and no provision for interest and penalties is deemed necessary as of December 31, 2022 and September 30, 2022.

**NOTE 10 - DEFERRED REVENUE**

During the three months ended December 31, 2022, the Company delivered $32,633 in the aggregate of software products to customers under one year subscription periods. The Company records the agreed to amounts over the one-year term of the subscription agreements as deferred revenue, classified as a liability on the balance sheet, and amortizes the deferred revenue over the subscription period. During the year ended September 30, 2021, the Company received $3,744 form a customer for a payment of a one- year subscription agreement. For the three months ended December 31, 2022, and 2021, the Company recognized $5,706 and $937, respectively, of revenue from these agreements. As of December 31, 2022, the balance of deferred revenues of $26,763 is included in the balance sheet.

**NOTE 11 - SUBSEQUENT EVENTS**

On January 3, 2023, the Company received $58,000 pursuant to a Licensing Agreement with Reticulate Micro. Pursuant to the license the Company issued a royalty free perpetual license for the software development of IGAN.

On January 10, 2023, the Company received $40,000 and issued a promissory note. The note matures January 10, 2024, and carries an 8% annual interest rate.

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements.

---

| |
|:---|
| 14 |
| *[**Table of Contents**](#Toc1)* |

---

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

*The following is management's discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying condensed consolidated financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words "believes," "anticipates," "may," "will," "should," "expect," "intend," "estimate," "continue," and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.*

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

The following discussion should be read in conjunction with our unaudited financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q.

**THE COMPANY**

Cytta Corp., ("Cytta" or the "Company") was incorporated on May 30, 2006 under the laws of the State of Nevada. It is located in Las Vegas, Nevada. Cytta is in the business of imagineering, developing and securing disruptive technologies.

**Results of Operations for the three months ended December 31, 2022 and 2021:**

Revenues of $5,706 and $937 for the three months ended December 31, 2022, and 2021, respectively, were from deferred revenue on subscription agreements being recognized.

Revenues consist of our proprietary software, integration consulting services, tech support and product maintenance billed to the customer. Revenues increased for the three months ended December 31, 2022, compared to the three months ended December 31, 2021, due to an increase in customers and the associated deferred revenue recognized on subscription agreements entered into and being recognized in the current quarter.

Operating expenses decreased by $12,543 for the three months ended December 31, 2022, over 2021 as shown in the table below:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| <br>**Description** | **2022** | **2021** |
| Stock based expenses | $551668 | $455985 |
| Professional fees | 53146 | 111296 |
| Consulting expenses (excluding stock expenses) | 199787 | 18450 |
| Related party expenses (excluding stock expenses) | 177868 | 426219 |
| Depreciation expense | 11904 | 11904 |
| Equipment and demo expenses | 25369 | 8981 |
| General and Administrative officers | 1606 | 3670 |
| Auto, Travel and Meals and Entertainment | 25530 | 28560 |
| Rent expense | 6116 | 4147 |
| Investor relations expense | 31162 | 13954 |
| Other operating expenses | 22287 | 35820 |
| Total Operating expenses | $1106443 | $1118986 |

---

---

| |
|:---|
| 15 |
| *[**Table of Contents**](#Toc1)* |

---

Stock-based expenses increased in the current period compared to the prior period. The current period expense includes $407,275 for the issuance of 3,925,000 shares to consultants. The expense is based on the price of the common stock on the dates the Company agreed to issued the shares. The Company also recorded $144,393 of expense related to commitments the Company incurred during the three months ended December 31, 2022. The $144,393 is included in accounts payable and accrued expenses on the December 31, 2022, balance sheet. The expense of $455,985 for the three months ended December 31, 2021, was a result of the amortization of $425,985 for shares of common stock previously issued and $30,000 for the cost of 250,000 shares issued during the quarter ended December 31, 2021.

Professional fees decreased in the current period compared to the prior period, substantially due to lower legal fees of approximately $44,000 in the current period, due to less costs associated with the Skoblow case in the current period.

Consulting expenses increased during the three months ended December 31, 2022, compared to the three months ended December 31, 2021, substantially as a result of $134,300 expensed for consultants providing product development and software costs. Also, additional consulting costs related to sales and marketing and finance of $55,000 were recognized for the three months ended December 31, 2022.

Related party expenses decreased for the three months ended December 31, 2022, compared to the three months ended December 31, 2021 as follows:

---

| | | |
|:---|:---|:---|
|  | **Three months ended** <br>December 31, | **Three months ended** <br>December 31, |
|  | **2022** | **2021** |
| Management fees, Chief Executive Officer (CEO) | $60000 | $145000 |
| Chief Technology Officer (CTO)  | 60000 | 145000 |
| Chief Administration Officer (CAO)  | 45000 | 120000 |
| Office rent and expenses | 12868 | 16219 |
| Total | $177868 | $426219 |

---

Effective June 1, 2021, the Company increased the monthly fee paid to its' CEO and CTO, from $12,000 to $15,000, respectively. On January 1, 2022, the Company increased the monthly fee to $18,000 for the CEO and CTO, respectively, and on February 1, 2022, the monthly fee for the CEO and CTO was increased to $20,000. For the three months ended December 31, 2021, the Company also recorded bonus expenses of $100,000, $100,000, and $90,000 for the CEO, CTO and CAO, respectively. For the three months ended December 31, 2022, and 2021, the Company expensed $45,000 and $45,000 to its CAO, respectively.

On October 25, 2020, the Company entered into a sublease with its CTO, whereby the Company agreed to an annual lease payment of $50,000. On October 26, 2021, renewed he lease for an additional year for $3,500 per month, and on October 26, 2022, the lease was renewed on a month-to-month basis. Included in office rent and expenses for the three months ended December 31, 2022, and 2021 is $10,500 and $14,663, respectively.

Investor relations fee increased for the three months ended December 31, 2022, compared to the three months ended December 31, 2021. The increase was primarily a result of the Company engaging additional consultants as well the Company attending trade shows and conferences to expose the Company to potential investors.

---

| |
|:---|
| 16 |
| *[**Table of Contents**](#Toc1)* |

---

The following tables set forth key components of our balance sheet as of December 31, 2022, and September 30, 2022.

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br>**2022** | **September 30,**<br>**2022** |
| Current Assets | $175263 | $788019 |
| Property and Equipment | $111086 | $122990 |
| Total Assets | $286349 | $911009 |
| Current Liabilities | $517990 | $449217 |
| Total Liabilities | $517990 | $449217 |
| Stockholders' Equity (Deficit) | $(231641) | $461792 |
| Total Liabilities and Stockholders' Equity | $286349 | $911009 |

---

**Liquidity and Capital Resources**

As of December 31, 2022, we had limited operating capital. Our current capital and our other existing resources will not be sufficient to provide the working capital needed for our current business Additional capital will be required to meet our obligations, and to further expand our business. We may be unable to obtain the additional capital required. Our inability to generate capital or raise additional funds when required will have a negative impact on our business development and financial results. These conditions raise substantial doubt about our ability to continue as a going concern as well as our recurring losses from operations and the need to raise additional capital to fund operations. This "going concern" could impair our ability to finance our operations through the sale of debt or equity securities.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2022, the Company had an accumulated deficit of $28,975,715 and has also generated losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern.

As of December 31, 2022, we had cash of $143,341 compared to $755,122 at September 30, 2021. As of December 31, 2022, we had current assets of $175,263 and current liabilities of $517,990, which resulted in working capital deficiency of $342,727. The current liabilities are comprised of accounts payable, accounts payable-related parties, accrued expenses, deferred revenue and stock to be issued.

In December 2019, a novel strain of coronavirus (COVID-19) emerged. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company's business and the duration for which it may have an impact cannot be determined at this time.

*Operating Activities*

For the three months ended December 31, 2022, net cash used in operating activities was $611,781 compared to $522,310 for the three months ended December 31, 2021. For the three months ended December 31, 2022, our net cash used in operating activities was primarily attributable to the net loss of $1,100,708, adjusted by stock-based compensation of $407,275 and depreciation of $11,904. Net changes of $69,748 in operating assets and liabilities decreased the cash used in operating activities.

---

| |
|:---|
| 17 |
| *[**Table of Contents**](#Toc1)* |

---

For the three months ended December 31, 2021, our net cash used in operating activities was primarily attributable to the net loss of $1,164,106, adjusted by stock-based compensation of $455.985 and depreciation of $11,904. Net changes of $173,906 in operating assets and liabilities decreased the cash used in operating activities.

*Investing Activities*

For the three months ended December 31, 2022, and 2021, there was no cash used in investing activities.

*Financing Activities*

For the three months ended December 31, 2022, there were no financing activities. For the three months ended December 31, 2021, net cash provided by financing activities was $2,963,500, pursuant to the sale of 59,270,000 shares of Series F Preferred Stock at $0.05 per share.

**Critical Accounting Policies**

Our significant accounting policies are summarized in Note 3 of our financial statements. While all these significant accounting policies impact our financial condition and results of operations, we view certain of these policies as critical. Policies determined to be critical are those policies that have the most significant impact on our financial statements and require management to use a greater degree of judgment and estimates. Actual results may differ from those estimates. Our management believes that given current facts and circumstances, it is unlikely that applying any other reasonable judgments or estimate methodologies would cause an effect on our results of operations, financial position or liquidity for the periods presented in this report.

*Accounts Receivable*

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

*Property and Equipment*

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

---

| | |
|:---|:---|
| Vehicles and equipment | 5 years |
| Software | 3 years |

---

*Revenue Recognition*

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. The Company has no outstanding contracts with any of its' customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms.

---

| |
|:---|
| 18 |
| *[**Table of Contents**](#Toc1)* |

---

*Stock-Based Compensation*

The Company accounts for its stock based compensation under the recognition and measurement principles of the fair value recognition provisions of Statement of Financial Accounting Standards No. 123 (revised 2004) "Share-Based Payment" ("SFAS No. 123R")(ASC 718) using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and the Financial Accounting Standards Board Emerging Issues Task Force Issue No. 96-18 "Accounting For Equity Instruments That Are Issued To Other Than Employees For Acquiring, Or In Conjunction With Selling Goods Or Services" ("EITF No. 96-18") for share-based payment transactions with parties other than employees provided in SFAS No. 123(R) (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the third-party performance is complete or the date on which it is probable that performance will occur.

*Earnings (Loss) Per Share*

The Company computes net loss per share in accordance with FASB ASC 260, "Earnings per Share." ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the statement of operations. Basic EPS is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive.

**Off Balance Sheet Arrangements**

We have no off-balance sheet arrangements including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk.**

Not Applicable.

**Item 4. Controls and Procedures.**

***Disclosure Controls and Procedures***

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the "Exchange Act"), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of December 31, 2022. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective for the reasons discussed below.

---

| |
|:---|
| 19 |
| *[**Table of Contents**](#Toc1)* |

---

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of December 31, 2022, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

1. We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management's view that such a committee, including a financial expert member, is an utmost important entity level control over the Company's financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management's activities.

2. We did not maintain appropriate cash controls – As of December 31, 2022, the Company has not maintained sufficient internal controls over financial reporting for cash, including failure to segregate cash handling and accounting functions, and did not require dual signatures on the Company's bank accounts. 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company's internal controls.

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

***Changes in Internal Controls over Financial Reporting***

There has been no change in our internal control over financial reporting occurred during the three months ended December 31, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

---

| |
|:---|
| 20 |
| *[**Table of Contents**](#Toc1)* |

---

**PART II. OTHER INFORMATION**

**Item 1. LEGAL PROCEEDINGS**

On November 24, 2020, Lee Skoblow (the "Plaintiff") filed a complaint in the State District Court for Clark County, Nevada, naming Cytta as a Defendant. The Plaintiff contends that the Company had breached an agreement. On or about January 15, 2021, the Defendant filed an Answer and Counterclaim in the litigation and also contended that in fact the Plaintiff owed money to Cytta having breached an earlier services agreement, of limited scope and duration, and was liable for defaming Cytta in various communications he had sent to certain persons or entities. Management has been contesting the matter vigorously. A bench trial was held in June 2022, and the court has not yet made a ruling.

Other than the above, we know of no material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

**Item 1A. RISK FACTORS**

Not applicable for smaller reporting companies.

**Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

The following represents all shares issued during the quarter ended December 31, 2022:

On December 2, 2022, the Company issued 500,000 shares of restricted common stock to an existing Company shareholder, in exchange for consulting services provided to the Company. The shares were valued at $0.086 per share, the market price on the date the Company agreed to issue the shares.

On December 2, 2022, the Company issued 150,000 shares of restricted common stock to a former consultant. The shares were valued at $0.095 per share, the market price on the date the Company agreed to issue the shares.

On December 2, 2022, the Company issued 500,000 shares of restricted common stock to an existing Company shareholder, in exchange for consulting services provided to the Company. The shares were valued at $0.10 per share, the market price on the date the Company agreed to issue the shares.

On December 2, 2022, the Company issued 250,000 shares of restricted common stock to an existing Company shareholder, in exchange for consulting services provided to the Company. The shares were valued at $0.1199 per share, the market price on the date the Company agreed to issue the shares.

On December 2, 2022, the Company issued 325,000 shares of restricted common stock to an existing Company shareholder, in exchange for consulting services provided to the Company. The shares were valued at $0.154 per share, the market price on the date the Company agreed to issue the shares.

On December 2, 2022, the Company issued 1,000,000 shares of restricted common stock in exchange for consulting services provided to the Company. The shares were valued at $0.10 per share, the market price on the date the Company agreed to issue the shares.

On December 2, 2022, the Company issued 1,200,000 shares of restricted common stock in exchange for consulting services provided to the Company. The shares were valued at $0.20 per share, the market price on the date the Company agreed to issue the shares.

The Company issued the foregoing securities in reliance on an exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) promulgated thereunder, as there was no general solicitation to the investors and the transactions did not involve a public offering.

**Item 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**Item 4. MINE SAFETY DISCLOSURE**

Not applicable.

**Item 5. OTHER INFORMATION**

(a) None.

(b) During the quarter ended December 31, 2022, there have not been any material changes to the procedures by which security holders may recommend nominees to the Board of Directors.

---

| |
|:---|
| 21 |
| *[**Table of Contents**](#Toc1)* |

---

**Item 6. EXHIBITS**

The following documents are filed as part of this report:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [3.1](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex31.htm) | [Articles of Incorporation of Cytta Corp.\*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex31.htm) |
| [3.2](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex32.htm) | [Bylaws of the Company \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex32.htm) |
| [3.3](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex33.htm) | [Amendment to Articles of Incorporation Amending Authorized Common and Preferred Stock \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex33.htm) |
| [3.4](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex34.htm) | [Amended and Restated Certificate of Designation of Series D Preferred Stock \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex34.htm) |
| [3.5](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex35.htm) | [Amended and Restated Certificate of Designation of Series E Preferred Stock \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex35.htm) |
| [3.6](http://www.sec.gov/Archives/edgar/data/1383088/000147793221008813/cyca_ex41.htm) | [Certificate of Designation of Series F Preferred Stock\*\*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221008813/cyca_ex41.htm) |
| [10.1](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex101.htm) | [Agreement by and between Cytta Corp and Makena Investment Advisors, LLC dated April 1, 2020 \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex101.htm) |
| [10.2](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex102.htm) | [Sublease Agreement by and between Cytta Corp and Michael Collins dated October 25, 2020 \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex102.htm) |
| [10.3](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex103.htm) | [Agreement by and between Cytta Corp and Peter Rettman dated August 27, 2020 \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex103.htm) |
| [10.4](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex104.htm) | [Share Issuance agreement by and between Cytta Corp and United Financial Inc., dated September 30, 2020 \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex104.htm) |
| [10.5](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex105.htm) | [Technology Access Agreement by and between Cytta Corp and Michael Collins dated July 19, 2018 \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex105.htm) |
| [14.1](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex141.htm) | [Code of Ethics \*](http://www.sec.gov/Archives/edgar/data/1383088/000147793221004297/cyca_ex141.htm) |
| [31.1](cyca_ex311.htm) | [Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002\*\*\*](cyca_ex311.htm) |
| [31.2](cyca_ex312.htm) | [Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002\*\*\*](cyca_ex312.htm) |
| [32.1](cyca_ex321.htm) | [Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63\*\*\*](cyca_ex321.htm) |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).\*\*\* |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document.\*\*\* |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.\*\*\* |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.\*\*\* |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document.\*\*\* |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.\*\*\* |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |

---

\* Incorporated by reference to the same exhibit to the registration statement filed by the Company on June 28, 2021.

\*\* Incorporated by reference to exhibit 4.1 to the Current Report on Form 8-K filed by the Company on November 26, 2021.

\*\*\* Filed herewith

---

| |
|:---|
| 22 |
| *[**Table of Contents**](#Toc1)* |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: February 14, 2023

---

| |
|:---|
| ***/s/ Gary Campbell*** |
| Gary Campbell |
| Chief Executive Officer |
| (principal executive officer) |
| (principal financial and accounting officer) |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION**

I, Gary Campbell, Chief Executive Officer of CYTTA CORP. (the "registrant"), certify that:

1. I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended December 31, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: February 14, 2023 | By: | */s/ Gary Campbell* |
|  |  | Gary Campbell |
|  |  | Chief Executive Officer |
|  |  | (principal executive officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION**

I, Gary Campbell, Chief Financial Officer of CYTTA CORP. (the "registrant"), certify that:

1. I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended December 31, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: February 14, 2023 | By: | */s/ Gary Campbell* |
|  |  | Gary Campbell |
|  |  | Chief Financial Officer |
|  |  | (principal financial and accounting officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Each of the undersigned hereby certifies, in his capacity as an officer of CYTTA CORP. (the "Company"), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1) The Company's Quarterly Report on Form 10-Q for the period ended December 31, 2022 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Dated: February 14, 2023 | By: | */s/ Gary Campbell* |
|  |  | Gary Campbell |
|  |  | Chief Executive Officer |
|  |  | (principal executive officer) |
|  |  | (principal financial and accounting officer) |

---